AviChina Industry & Technology Co Ltd (AviChina), a subsidiary of Aviation Industry Corp of China, Ltd, is a manufacturer of aviation products. The company primarily engages in the development, manufacture, sales, and upgrade of civil aviation and defense products, including helicopters, trainers, general-purpose aircraft, and regional jets for both domestic and international customers. AviChina's business portfolio includes the development and provision of helicopters, trainer aircraft, general-purpose aircraft, and regional jets for both domestic and international customers. Its principal products include the Z-series and AC series helicopters, L15, K8, and CJ6 trainer series, Y12 multi-purpose aeroplanes, and N5 agricultural aeroplanes.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

AviChina undertook several R&D initiatives, including the development of new model programs in the trainer business, strengthening scientific and technological innovation in the aviation ancillary system, and focusing on digital and intelligent transformation. The company also emphasized the development of core technologies for low-altitude aircraft and the transformation of scientific and technological achievements to promote integration with strategic emerging industries. The R&D units of AviChina include JONHON, which focuses on civil aircraft and industrial parks, and Shaanxi Huayan, which collaborates with Shanghai Jiao Tong University to promote original innovation in intelligent sensing. These units are responsible for managing the company's R&D activities and enhancing technological capabilities. In FY2025, the company incurred expenses of CNY6,155 million on R&D, which, as a percentage of revenue, stood at 6.9%.